Mental illness rates high among hard-to-reach people with HIV/AIDS in B.C.: Study

More than half of people in the B.C. Centre for Excellence in HIV/AIDS’s drug treatment program have suffered from mental illness

Addressing the underlying mental health issues of harder-to-reach people with HIV/AIDS is important for treatment, a British Columbia researcher says.

The B.C. Centre for Excellence in HIV/AIDS (BC-CfE) studied 916 participants in its drug treatment program from 2007 to 2010 and found that more than half (54 per cent) reported having a mental health disorder at some point in their lives.

The rate of mental illness among people with HIV is two to 10 times higher that the general population’s, according to previous research.

BC-CfE research scientist Dr. Robert Hogg told Metro that mood (85 per cent) and anxiety (65 per cent) disorders were the most common mental health conditions among the group.

The study defines “harder to reach” people as those with HIV/AIDS who use illicit drugs, have other health complications or are from vulnerable populations, such as women or Indigenous people, who can experience significant barriers to treatment for the disease.

“We were just amazed at the rate of concurrent illness with mental health-related issues,” said Hogg. “We wanted to make sure people are aware. People [dealing with mental illness] may not be accessing therapy or addressing their mental health concerns. Certainly, that’s an important thing to deal with.”

While dealing with concurrent illnesses is vital to ensuring the health of people with HIV/AIDS, the good news, according to Hogg, is that HIV/AIDS treatment adherence for people who are in the program and suffer from mental illness was roughly the same as those who don’t have a mental health illness.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below